Last Price
1.20
Today's Change
+0.556 (86.33%)
Day's Change
0.658 - 1.35
Trading Volume
18,089,507
Profile
INVO
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Steven M. Shum Mr. Steven M. Shum
Full Time Employees: 25 25
IPO Date: 2020-11-02 2020-11-02
CIK: 0001417926 0001417926
ISIN: US44984F4019 US44984F4019
CUSIP: 44984F302 44984F302
Beta: 1.44 1.44
Last Dividend: 0.00 0.00
Dcf Diff: 0.00 0.00
Dcf: 0.00 0.00
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Uniqlo Owner Targets Higher Sales From Strong Western Market
2
CEO Morning Brief
3
4
CEO Morning Brief
5
CEO Morning Brief
#
Stock
Score
9
First Trust Exchange-Traded Fund Viii - Cboe Vest U S Equity Buffer and Premium Income Etf
625
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
